⌘K
t
Indivior PLC announced on May 13, 2025, that its Chief Executive Officer, Joe Ciaffoni, and Chief Financial Officer, Ryan Preblick, will participate in three investor events. They will host 1x1 / group meetings at the Jefferies Global Healthcare Conference on June 4th, the Goldman Sachs 46th Annual Global Healthcare Conference on June 11th, and the Northland Growth Conference 2025 on June 25th. Mr. Ciaffoni will also participate in a fireside discussion at the Jefferies conference on June 4th at 9:55 a.m. U.S. ET.
| Date | 13 May 2025 |
| Time | 15:00:00 |
| Category | Miscellaneous |
| ID | 5042I |
Indivior to Participate in Upcoming Investor Events
Richmond, VA, May 13, 2025 - Indivior PLC (NASDAQ/LSE: INDV) today announced that it will participate in the following investor events:
· Jefferies Global Healthcare Conference - New York City, NY
Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Wednesday, June 4th. Joe Ciaffoni will also participate in a fireside discussion on Wednesday, June 4th at 9:55 a.m. U.S. ET. Interested investors should contact their Jefferies representative to schedule a meeting. The fireside discussion will be publicly available and can be viewed using the following weblink:
· Goldman Sachs 46th Annual Global Healthcare Conference - Miami, FL
Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Wednesday, June 11th. Interested investors should contact their Goldman Sachs representative to schedule a meeting.
· Northland Growth Conference 2025 - Virtual
Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings virtually on Wednesday, June 25th. Interested investors should contact their Northland representative to schedule a meeting.
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD). Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-402-7123 or jason.thompson@indivior.com
Tim Owens
Director, Investor Relations
Tel: 804-263-3978 or timothy.owens@indivior.com
###